Liquidia Corp. (LQDA)
37.65
+0.31
(+0.83%)
USD |
NASDAQ |
Apr 28, 16:00
37.67
+0.02
(+0.05%)
After-Hours: 20:00
Liquidia Research and Development Expense (TTM) : 38.35M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| ANI Pharmaceuticals, Inc. | 51.66M |
| ADMA Biologics, Inc. | 4.761M |
| Lexicon Pharmaceuticals, Inc. | 60.50M |
| aTyr Pharma, Inc. | 60.22M |
| Kura Oncology, Inc. | 251.07M |